Skip to Main Content
Lantern_Icon_blue
Lantern by Labaton
Link_Arrow
ClientConnect_Icon_blue
Client Connect
Link_Arrow
Labaton Logo
  • The Firm
  • Practices
  • Our Team
  • Cases
  • News & Insights
  • Client Services
  • Careers
Contact Us
Established 1963

Back to Resolved Cases
Practice Area: Securities Litigation
Updated: July 26, 2010

In re HealthSouth Securities Litigation

Case Materials

Partial Final Judgment and Order of Dismissal with Prejudice as to UBS Defendants
Notice of Proposed Settlement of Class Action with UBS Defendants
Order Preliminarily Approving Settlement with UBS Defendants and Providing for Notice
UBS Proof of Claim and Release Form
Stipulation of Settlement with UBS Defendants
Ernst & Young LLP Proof of Claim Instructions and Form
Stipulation of Settlement with Ernst & Young LLP
Notice of Proposed Settlement of Class Action with Ernst & Young LLP
Stipulation of Partial Settlement
Preliminarily Approving Partial Settlement
Notice of Pendency and Proposed Partial Settlement of Class Action

Labaton Keller Sucharow served as co-lead counsel in In re HealthSouth Corporation Securities Litigation, a case stemming from the largest fraud ever perpetrated in the healthcare industry.  On behalf of the New Mexico State Investment Council and the Educational Retirement Board of New Mexico, the Firm, along with co-counsel, filed a class action suit under federal securities laws alleging that HealthSouth falsified its revenues and funded a series of massive corporate acquisitions for the purpose of perpetrating a systematic Medicare and accounting fraud.  The complaint asserts that while company executives misled investors into buying the company's stock, they sold vast amounts of their own personal shares of HealthSouth stock for huge profits.  The plaintiffs also allege that HealthSouth was able to keep its fraudulent practices hidden from the public through the assistance of its auditors, Ernst & Young, and its principal banker, UBS, among others.  The lead plaintiffs alleged that Ernst & Young accepted millions of dollars in purported auditing and consulting fees in exchange for turning a blind eye to the Company's accounting fraud.  Similarly, the plaintiffs alleged that UBS profited from its role in concealing HealthSouth's fraud through orchestrating deceptive financial transactions, withholding information about the true financial condition of the company, and making false statements about HealthSouth's financial condition, including the publication of false analyst reports aimed at deceiving investors into believing that HealthSouth was a healthy and legitimate company.  All the while, the lead plaintiffs alleged, Ernst & Young and UBS were fully aware, and indeed an integral part, of the historic fraud perpetrated on HealthSouth's stockholders.  Evidence presented in connection with the guilty pleas and criminal convictions of 15 former company employees has buttressed the lead plaintiffs' prosecution of this case.

In early 2006, the lead plaintiffs negotiated a settlement valued at $445 million with HealthSouth Corporation and several of the company's former officers and directors, which was approved by the Court on January 11, 2007.  The HealthSouth partial settlement, comprised of cash and HealthSouth securities, is one of the largest in history.  On June 12, 2009, the court also granted final approval to a $109 million settlement with defendant Ernst & Young LLP, which at the time was believed to be the eighth largest securities fraud class action settlement with an auditor.  On July 26, 2010, the court approved a $117 million settlement with the remaining principal defendants in the case, UBS AG, UBS Warburg LLC, Howard Capek, Benjamin Lorello and William McGahan (the UBS defendants).  The settlements are being distributed to Authorized Claimants.

The total value of the settlements for Healthsouth stockholders and Healthsouth bondholders, who were represented by separate counsel, is $804.5 million, which is the eleventh largest settlement filed after the passage of the PSLRA based on the SCAS 100 for the first quarter of 2010.

logo

Our Locations

New York

140 Broadway
New York, NY 10005
Tel: +1 212.907.0700

Delaware

222 Delaware Avenue, Suite 1510
Wilmington, DE 19801
Tel: +1 302.573.2540

London

1 King William Street
London, EC4N 7AF United Kingdom
Tel: +44 20 3582 0981

Washington, D.C.

1050 Connecticut Avenue NW, Suite 500
Washington, D.C. 20036
Tel: +1 202.772.1881

Useful Links

  • Practices
  • Cases
  • News & Insights
  • Client Services
  • Contact

The Firm

  • Our Team
  • Our Story
  • Awards & Accolades
  • Offices
  • Social Commitment
  • Careers for Attorneys
  • Careers for Business Professionals
  • Attorney Development

Stay Connected

fbfb
Facebook
Xx
Twitter / X
inin
LinkedIn
Footer_Graphic
© Labaton Keller Sucharow LLP All Rights Reserved 2026
Attorney Advertising DisclaimerPrivacy PolicyCookie PolicyCalifornia Privacy Policy and Notice of Collection of Personal InformationTransparency in Coverage Rule